Atlas Trials

Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)

RecordFirmDate
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients (NCT01837511)GlaxoSmithKline2007-08-01

Track Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC) automatically

Every clearance here is in the API, with alerts when new ones post.